These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33629099)

  • 1. Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection.
    Inghammar M; Svanström H; Voldstedlund M; Melbye M; Hviid A; Mølbak K; Pasternak B
    Clin Infect Dis; 2021 Jun; 72(12):e1084-e1089. PubMed ID: 33629099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
    Freedberg DE; Salmasian H; Friedman C; Abrams JA
    Am J Gastroenterol; 2013 Nov; 108(11):1794-801. PubMed ID: 24060760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
    Faleck DM; Salmasian H; Furuya EY; Larson EL; Abrams JA; Freedberg DE
    Am J Gastroenterol; 2016 Nov; 111(11):1641-1648. PubMed ID: 27575714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.
    McDonald EG; Milligan J; Frenette C; Lee TC
    JAMA Intern Med; 2015 May; 175(5):784-91. PubMed ID: 25730198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.
    Barletta JF; Sclar DA
    Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
    Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
    Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
    Stevens V; Dumyati G; Brown J; Wijngaarden E
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study.
    Park YH; Seong JM; Cho S; Han HW; Kim JY; An SH; Gwak HS
    J Gastroenterol; 2019 Dec; 54(12):1052-1060. PubMed ID: 31187275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vonoprazan poses no additional risk of developing Clostridioides difficile infection compared to proton pump inhibitors.
    Saruta Y; Watanabe K; Tsuji T; Takahashi Y; Matsuzawa H; Yoshida T; Takahashi S; Shimodaira Y; Matsuhashi T; Iijima K
    J Gastroenterol Hepatol; 2023 Jun; 38(6):940-947. PubMed ID: 36882162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.
    Chitnis AS; Holzbauer SM; Belflower RM; Winston LG; Bamberg WM; Lyons C; Farley MM; Dumyati GK; Wilson LE; Beldavs ZG; Dunn JR; Gould LH; MacCannell DR; Gerding DN; McDonald LC; Lessa FC
    JAMA Intern Med; 2013 Jul; 173(14):1359-67. PubMed ID: 23780507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.
    Dial S; Alrasadi K; Manoukian C; Huang A; Menzies D
    CMAJ; 2004 Jul; 171(1):33-8. PubMed ID: 15238493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional differences in Clostridium difficile infections in relation to fluoroquinolone and proton pump inhibitor use, Finland, 2008-2011.
    Kanerva M; Ollgren J; Voipio T; Mentula S; Lyytikäinen O
    Infect Dis (Lond); 2015 Aug; 47(8):530-5. PubMed ID: 25832317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Hospital-Acquired
    Azab M; Doo L; Doo DH; Elmofti Y; Ahmed M; Cadavona JJ; Liu XB; Shafi A; Joo MK; Yoo JW
    Gut Liver; 2017 Nov; 11(6):781-788. PubMed ID: 28506028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.
    Oshima T; Wu L; Li M; Fukui H; Watari J; Miwa H
    J Gastroenterol; 2018 Jan; 53(1):84-94. PubMed ID: 28744822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model.
    Hung YP; Ko WC; Chou PH; Chen YH; Lin HJ; Liu YH; Tsai HW; Lee JC; Tsai PJ
    J Infect Dis; 2015 Aug; 212(4):654-63. PubMed ID: 25805751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
    Kimura T; Snijder R; Sugitani T
    J Infect Chemother; 2019 Aug; 25(8):615-620. PubMed ID: 30987950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis.
    Arriola V; Tischendorf J; Musuuza J; Barker A; Rozelle JW; Safdar N
    Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1408-1417. PubMed ID: 27677811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
    Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does PPI therapy predispose to Clostridium difficile infection?
    Pant C; Madonia P; Minocha A
    Nat Rev Gastroenterol Hepatol; 2009 Sep; 6(9):555-7. PubMed ID: 19713988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.